🔗 Share this article

A shadow market for unlicensed weight-loss drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.

Experimental Treatment Acquiring Popularity Via Social Media

The experimental drug, which is still in clinical trials, is being advertised by online personalities for its supposed fat-burning properties. Viewers are urged to message these accounts directly for source information, while also receiving promotional offers.

Active Commerce on Social Networks

Separately, a flourishing trade exists on messaging services, where communities with numerous of members share “before and after” images, injection guides and claims of rapid British shipping. Sellers promote the substance there before directing customers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.

Healthcare Experts Voice Worries

However, physicians and chemists have cautions that the distribution of what is still an unlicensed medication in the United Kingdom is worrisome and could result in users administering products of unknown origin.

Some professionals stated the popularity for the experimental drug could be linked to the rising cost of licensed weight loss products such as Mounjaro.

Legal Status and Enforcement

Marketing the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed medication that cannot be promoted or supplied for human use under the British medical regulations.

Some influencers try to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still breach medicines, advertising, and customer laws, potentially leading to penalties, prosecution or imprisonment.

Platform Reaction and Material Removal

Based on TikTok, the service has taken down violative content and banned associated hashtags and search suggestions. The company stated it was committed to keeping the platform secure and allocating resources in enhancing compliance measures.

Digital Trading Operations

Research also found groups with up to 9,000 participants selling retatrutide using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” immediately brings up channels with thousands of members, populated with photos of slimming results, positive testimonials and detailed instructions for preparing or administering at home.

After minutes of entering one group, a vendor posted contact information, where the majority of purchases take place. The seller sent an instruction manual and guaranteed shipping within 48 hours. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one inquired about weight, medical conditions or past usage.

Product Information and Costs

Inside these communities, posts show dark colored parcels with postal service labels, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at residence with sterile water, or ready-to-use pens usually sold at 160 pounds for 20mg. When asked how long a pen should be used, vendors give conflicting answers varying between a several days to “depends on your body”.

Platform Moderation and Safety Actions

A representative for the messaging service stated it actively monitored dangerous material on its service including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are administering substances they can’t verify. Although the science behind this drug is sound, these digital products may not contain what they claim,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor connected the increase in demand to recent price rises for authorized slimming medications such as Mounjaro. “With prices rising, patients are turning to social media. But counterfeit injections are extremely risky. You cannot know what’s inside or whether the environment they were made in was sterile,” she said.

Her staff has already encountered patients harmed by self-injection from unverified suppliers. “We understand the frustration, but purchasing from Telegram or communication platforms is taking chances with your health,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Statement

A representative from the pharmaceutical company stated the substance was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this point no one can market [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a Lilly investigational substance not yet approved … may expose users to possibly significant medical dangers”.